Company news
Telix Pharmaceuticals Limited news in 2021
Telix Pharmaceuticals Limited's news releases, calls and decks from 2021, newest first.
Targeted Alpha Therapy for Bladder Cancer 1st patient dosed
December 20, 2021
FDA Approves Telix Prostate Cancer Imaging Product Illuccix
December 19, 2021
Illuccix EU Regulatory Submission Progress Update
December 9, 2021
NUCLIBER - Distribution Agreement for Illuccix in Spain
December 7, 2021
Illuccix Granted Use Authorisation in Brazil
November 30, 2021
Investor Presentation - November 2021
November 15, 2021
Australian TGA Approves Illuccix for Prostate Cancer Imaging
November 1, 2021
Activities Report and App 4C - September 2021 quarter
October 20, 2021
IPAX-1 Presentation at Congress of Neurological Surgeons
October 19, 2021
$12.1M R&D Tax Refund, Overseas Finding Increased to $139M
September 27, 2021
FDA Extends New Drug Application Review Period for Illuccix
September 22, 2021
FDA Approves Phase II Kidney Cancer Therapy Study
September 13, 2021
Telix and Radius sign Distribution Agreement for Italy
September 12, 2021
Results Presentation and Shareholder Update 1H 2021
August 18, 2021
App 4D and Report for Half-Year Ended 30 June 2021
August 18, 2021
Telix and Merck pan-cancer clinical collaboration
August 17, 2021
TLX66 in Phase II Academic Study of Pediatric Leukemia
August 16, 2021
Telix Seneffe Production Facility - Progress Update
July 29, 2021
App 4C and Activities Report for June 2021 Quarter
July 21, 2021
ZIRCON Phase 3 Renal Cancer Imaging Study - Progress Update
July 19, 2021
TLX101 for Glioblastoma Therapy - Clinical Trial Update
June 20, 2021
Update on FDA New Drug Application Review for Illuccix
June 16, 2021
US Co-Promotion with EZAG for Prostate Cancer Imaging
June 3, 2021
TLX66 Meets Study Objectives in Patients with AL Amyloidosis
May 24, 2021
German Distribution Agreement with Eckert and Ziegler
May 17, 2021
Phase III Prostate Cancer Therapy Clinical Trial Commences
May 9, 2021
Activities Report and App 4C for quarter ended 31 March 2021
April 21, 2021
Japanese Renal Cancer Imaging Trial Meets Study Objectives
April 20, 2021
Launch of International NOBLE Registry for SPECT Imaging
April 18, 2021
TGA commences priority evaluation process for Illuccix
April 13, 2021
S&P DJI Announces March 2021 Quarterly Rebalance
March 12, 2021
Appendix 4E - Results for announcement to the market
February 25, 2021
Shareholder update - year ended 31 December 2020
February 25, 2021
Czech Republic Grants National Authorisation for TLX591 Kit
February 15, 2021
Appendix 4C and Activities Report for December 2020 Quarter
January 28, 2021
Decks in 2021
- Investor Presentation (November 2021)
Investor deck · 38 slides · Nov 16, 2021
- H1 2021 Earnings Presentation
Earnings · 31 slides · Aug 19, 2021
- Jefferies Healthcare Conference 2021
Conference · 25 slides · Jun 2, 2021